Late relapse in osteosarcoma

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 7, 2006, Pages 418-422

  Ferrari, Stefano ^a   Briccoli, Antonio ^b   Mercuri, Mario ^b   Bertoni, Franco ^c   Cesari, Marilena ^a   Longhi, Alessandra ^a   Bacci, Gaetano ^a  

^a Chemotherapy   (Italy)

^b NONE   (Italy)

^c Pathology   (Italy)

Author keywords

Late relapse; Osteosarcoma; Prognostic factors

Indexed keywords

ALKALINE PHOSPHATASE; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PREDICTION; PRIORITY JOURNAL; PROBABILITY; SEX DIFFERENCE; TUMOR VOLUME;

ADOLESCENT; ADULT; BONE NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; REMISSION INDUCTION; RISK FACTORS; SURVIVAL RATE; TIME;

EID: 33746373462     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000212944.82361.1d     Document Type: Article

References (17)

1. Meyers PA, Gorlick R, Heller G, et al. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T-12) protocol. J Clin Oncol. 1998;16:2452-2458.
2. Fuchs N, Bielack SS, Epler D, et al. Long-term results of the cooperative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol. 1998;9:893-899.
3. Bacci G, Ferrari S, Bertoni F, et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol. 2000;18:4016-4027.
4. Bacci G, Briccoli A, Ferrari S, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol. Eur J Cancer. 2001;37:2030-2039.
5. Meyers PA, Heller G, Healey J, et al. Chemotherapy for nonmetastatic Osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol. 1992;10:5-15.
6. Ferrari S, Bertoni F, Mercuri M, et al. Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol. 2001;12:1145-1150.
7. Bielack S, Kempf-Bielack B, Delling G, et al. Prognostic factors in high grade Osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2002;20:776-790.
8. Ferrari S, Briccoli A, Mercuri M, et al. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. J Clin Oncol. 2003;21:710-715.
9. Strauss SJ, McTiernan A, Whelan JS. Late relapse of osteosarcoma: implications for follow-up and screening. Pediatr Blood Cancer. 2004;43:692-697.
10. Kempf-Bielack B, Bielack S, Jurgens H, et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol. 2005;23:559-568.
11. Saeter G, Kloke O, Jelic S. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of osteosarcoma. Ann Oncol. 2005;16:i71-i72.
12. Korholz D, Verheyen J, Kemperdick HF, et al. Evaluation of follow-up investigations in osteosarcoma patients: suggestions for an effective follow-up program. Med Pediatr Oncol. 1998;30:52-58.
13. Brenner DJ, Ellison CD, Hall EJ, et al. Estimated risk of radiation-induced fatal cancer from pediatric CT. AJR. 2001;176:289-296.
14. Ferrari S, Bacci G, Picci P, et al. Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol. 1997;8:765-771.
15. Bacci G, Ferrari S, Longhi A, et al. High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study. J Chemother. 2002;14:198-206.
16. Grimer RJ, Sommerville S, Warnock D, et al. Management and outcome after local recurrence of osteosarcoma. Eur J Cancer. 2005;41:578-583.
17. Bacci G, Ferrari S, Mercuri M, et al. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand. 1998;69:230-236.